Search

Search Constraints

You searched for: Author/Creator Osman, Iman

Search Results

1. 194 A multicenter characterization of chronic toxicities following adjuvant anti-PD-1 therapy for high risk resected melanoma. (10th December 2020)

2. 194 A multicenter characterization of chronic toxicities following adjuvant anti-PD-1 therapy for high risk resected melanoma. (9th November 2020)

4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

6. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

7. Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis. (7th November 2021)

8. Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis. Issue 1 (18th May 2018)

9. Association between Ki‐67 expression and clinical outcomes among patients with clinically node‐negative, thick primary melanoma who underwent nodal staging. Issue 1 (7th June 2018)

10. Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer. Issue 2 (20th November 2020)